| AP-1 | Activating protein-1 |
| Ang II | Angiotensin II |
| ATP | Adenosine-triphosphate |
| AR | Aldose reductase |
| ACE | Angiotensin-converting enzyme |
| AKI | Acute kidney injury |
| ACE | Angiotensin-converting enzyme |
| α-SMA | α-Smooth muscle actin |
| BP | Blood pressure |
| BUN | Blood urea nitrogen |
| Ca2+ | Calcium |
| cGMP | Cyclic guanosine monophosphate |
| COX-2 | Cyclooxygenase-2 |
| CDKN2a | Cyclin-dependent kinase inhibitor 2a |
| CKD | Chronic kidney disease |
| CTGF | Connective tissue growth factor |
| DIR | D1 receptor |
| D2R | D1 receptor |
| DIC | Disseminated intravascular coagulation |
| ER | Estrogen receptor |
| EGF | Epidermal growth factor |
| ERK2 | Extracellular signal-regulated kinase 2 |
| Evs | Extracellular vesicles |
| ECM | Extracellular matrix |
| EPO | Erythropoietin |
| EED | Embryonic ectoderm development |
| ESRD | End-stage renal disease |
| eNOS | Endothelial NO synthase |
| Fos | c-Fos gene |
| FAK | Focal adhesion kinase |
| FGF | Fibroblast growth factor |
| FBG | Fasting blood glucose |
| GFAT | Glutamine:fructose-6-phosphate amidotransferase |
| GGT | Gamma-glutamyl transferase |
| HIF-1 | Hypoxia-inducible factor 1 |
| HGF | Hepatocyte growth factor |
| HSP70 | Heat shock protein 70 |
| HG | High glucose |
| HOTAIR | HOX transcript antisense RNA |
| HO-1 | Heme oxygenase-1 |
| IL-1β | Interleukin-1 beta |
| IP3 | Inositol triphosphate |
| IGF-I | Insulin-like growth factor-I |
| IRF3 | Interferon regulatory factor 3 |
| IL-6 | Interleukin-6 |
| I/R | Ischemia/reperfusion |
| ICAM | Intercellular adhesion molecule-1 |
| L-dopa | l-Dihydroxyphenylalanine |
| LysoPC | Lysophosphatidylcholine |
| LPS | Lipopolysaccharide |
| LDH | Lactate dehydrogenase |
| MC | Glomerular mesangial cells |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MAPK | Mitogen-activated protein kinases |
| MAP | Mitogen-activated protein |
| mTOR | Mammalian target of rapamycin |
| MyD88 | Myeloid differentiation primary response 88 |
| MVD | Microvessel density |
| MGO | Methylglyoxal |
| MDCK | Madin-Darby canine kidney |
| MDA | Malondialdehyde |
| NF-κB | Nuclear factor NF-kappaB |
| NO | Nitric oxide |
| NOS | Nitric oxide synthesis |
| NKA | Na (+), K (+)-ATPase |
| NHE | Na+/H+ exchanger |
| NGF | Nerve growth factor |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NP | p-Nonylphenol |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NQO1 | NAD(P)H:Quinone Oxidoreductase 1 |
| PDGF | Platelet-derived growth factor |
| PGE2 | Prostaglandin E2 |
| PLA2 | Phospholipase A2 transcription |
| PLC-γ1 | Phospholipase C-γ1 |
| PAI-1 | Plasminogen activator inhibitor-1 |
| PTK | Phototherapeutic keratectomy |
| PKC | Protein kinase C |
| PAH | Phenylalanine hydroxylase |
| Pax-2 | Paired homeobox-2 gene |
| Pi | Phosphate |
| PTH1R | Parathyroid hormone 1 receptor |
| Pa | Albumin permeability |
| PRC2 | Polycomb repressive complex 2 |
| PKC-βII | Protein kinase C-βII |
| PTH | Parathyroid hormone |
| RAGE | Receptor for advanced glycation end products |
| Ras | Renin–angiotensin system |
| RCC | Renal cell carcinoma |
| ROS | Reactive oxygen species |
| RT | Radiation therapy |
| SAPK | c-Jun phosphorylation |
| SMIT | Sodium/myo-inositol cotransporter |
| SNAP | s-Nitroso-N-acetyl-penicillamine |
| SMARCB1 | Subfamily B member 1 |
| SHR-SPs | Stroke-prone spontaneously hypertensive rats |
| TGF-β | Transforming growth factor-β |
| TRPV5 | Transient receptor potential vanilloid 5 |
| TLR4-MD2 | Toll-like receptor 4- myeloid differentiation 2 |
| TRIF | TIR domain-containing adapter-inducing interferon-beta |
| TNF-α | Tumor necrosis factor α |
| TLR-4 | Toll-like-receptor-4 |
| UTP | Uridine triphosphate |
| UUO | Unilateral ureteral obstruction |
| VPF | Vascular permeability factor |
| VEGF | Vascular endothelial growth factor |
| 5-HT2A | 5-Hydroxytryptamine 2A |
| 15d-PGJ2 | 15-Deoxy-delta12,14-prostaglandin J2 |